Clinical information

 
Evidence about the safety and efficacy of secretion clearance devices is well documented and continues to grow.

To further the understanding of conditions like bronchiectasis and COPD and their treatment, RespirTech is committed to supporting and sharing scientific research on chronic respiratory conditions and the use of secretion clearance devices.

Clinical posters

Case finding COPD and comorbid non-CF bronchiectasis in rural upstate New York: Keystone to successful COPD population health management – Clinical poster presented at American Thoracic Society (ATS) 2019 Conference.

Two years of high frequency chest wall oscillation (HFCWO) outcomes in a large registry of non-CF bronchiectasis patients – Clinical poster presented at American Thoracic Society (ATS) 2019 Conference

High frequency chest wall oscillation (HFCWO) responder analysis in a large registry of non-CF bronchiectasis patients – Clinical poster presented at American Thoracic Society (ATS) 2019 Conference 

Outcomes of high frequency chest wall oscillation (HFCWO) in COPD patients without bronchiectasis – Clinical poster presented at the 2019 CHEST meeting

Outcomes with HFCWO in bronchiectasis or COPD – Clinical poster presented at American Thoracic Society (ATS) 2017 Conference

Economic burden of bronchiectasis and COPD in U.S. – Clinical poster presented at American Thoracic Society (ATS) 2017 Conference 

Outcomes with High-Frequency Chest Wall Oscillation among Patients with COPD using a Large Claims Database – Clinical poster presented at the 2020 CHEST meeting

A Retrospective Real-World Cohort Study Demonstrating the Impact of HFCWO Therapy on Patients with Neuromuscular Disorders – Clinical poster presented at the 2020 CHEST meeting

Clinical articles

RespirTech supports and shares scientific research to further understanding of chronic respiratory conditions and how they may be managed.

Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis
Peer-reviewed paper published in Therapeutic Advances in Respiratory Disease, June 2019

Prevalence and incidence of non-CF bronchiectasis – Research paper published in Chronic Respiratory Disease

Healthcare utilization, expenditures in comorbid bronchiectasis and COPD – Paper published in Chronic Respiratory Disease

HFCWO Therapy: Weighing the Evidence article – published in Respiratory Therapy Magazine 2019 article

Focus on Bronchiectasis/COPD Overlap: An Under-Recognized but Critically Important Condition published in Respiratory Therapy Magazine 2018 article

Cost savings associated with HFCWO therapy white paper

Optimization of secretion clearance with the high frequency chest wall oscillation triangle waveform published in Respiratory Therapy Magazine 2016 article

Adaptive high frequency chest wall oscillation (HFCWO) therapy for maximum patient adherence: A patient-centered approach Paper published in Respiratory Therapy Magazine 2019 article

Lung Volume Recruitment: Maximize the Therapeutic Impact from Mechanical Insufflation-Exsufflation (MI-E) Devices published in Respiratory Therapy Magazine 2020 article

High Frequency Chest Wall Oscillation (HFCWO) Therapy: A Change in Plan – published in Respiratory Therapy Magazine 2021

Conditions that challenge respiratory health

Conditions that challenge respiratory health

We help patients with conditions that produce excess lung secretions clear their airways – for better breathing and respiratory health.

Breathe easier

Solutions and support to help you breathe easier

RespirTech helps patients, caregivers and healthcare providers breathe easier with proven technology and the assistance of our licensed respiratory specialists.

Respitech

5905 Nathan Lane North, Suite 200, Plymouth, MN 55442

©2021 Koninklijke Philips N.V. All rights reserved.

You are about to visit a Philips global content page

You are about to visit the Philips USA website.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.